CANDIDO, SAVERIO
 Distribuzione geografica
Continente #
NA - Nord America 5.540
EU - Europa 3.117
AS - Asia 2.778
SA - Sud America 503
AF - Africa 396
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 12.342
Nazione #
US - Stati Uniti d'America 5.377
SG - Singapore 1.374
IT - Italia 966
RU - Federazione Russa 938
CN - Cina 713
BR - Brasile 430
IE - Irlanda 384
VN - Vietnam 286
CI - Costa d'Avorio 215
UA - Ucraina 204
DE - Germania 170
FR - Francia 133
CA - Canada 120
KR - Corea 83
NG - Nigeria 80
IN - India 56
GB - Regno Unito 52
BD - Bangladesh 51
FI - Finlandia 48
NL - Olanda 42
SE - Svezia 41
SN - Senegal 37
MX - Messico 30
AR - Argentina 28
IQ - Iraq 28
HK - Hong Kong 27
PL - Polonia 27
TR - Turchia 27
ES - Italia 23
ZA - Sudafrica 22
CH - Svizzera 18
JP - Giappone 18
ID - Indonesia 16
PK - Pakistan 16
AT - Austria 14
UZ - Uzbekistan 13
CO - Colombia 12
IR - Iran 12
KE - Kenya 11
VE - Venezuela 10
CL - Cile 7
GR - Grecia 7
KZ - Kazakistan 7
BE - Belgio 6
BG - Bulgaria 6
CZ - Repubblica Ceca 6
JO - Giordania 6
LT - Lituania 6
NP - Nepal 6
PE - Perù 6
AU - Australia 5
BJ - Benin 5
EC - Ecuador 5
EG - Egitto 5
LB - Libano 5
MA - Marocco 5
MY - Malesia 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
OM - Oman 4
PT - Portogallo 4
RO - Romania 4
TN - Tunisia 4
AZ - Azerbaigian 3
BY - Bielorussia 3
CR - Costa Rica 3
DZ - Algeria 3
HR - Croazia 3
KG - Kirghizistan 3
AO - Angola 2
BO - Bolivia 2
CM - Camerun 2
ET - Etiopia 2
IL - Israele 2
MT - Malta 2
NI - Nicaragua 2
NO - Norvegia 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
CG - Congo 1
CU - Cuba 1
DO - Repubblica Dominicana 1
EU - Europa 1
JM - Giamaica 1
KI - Kiribati 1
KW - Kuwait 1
LI - Liechtenstein 1
LY - Libia 1
MN - Mongolia 1
MU - Mauritius 1
PA - Panama 1
PH - Filippine 1
PR - Porto Rico 1
PY - Paraguay 1
QA - Qatar 1
RS - Serbia 1
Totale 12.339
Città #
Dallas 1.158
Singapore 806
Santa Clara 683
Chandler 420
San Jose 416
Moscow 406
Dublin 376
Jacksonville 278
Catania 261
Ashburn 228
Chicago 222
Abidjan 215
Boardman 151
Beijing 138
Los Angeles 113
Cambridge 100
Lawrence 100
Lauterbourg 98
Hefei 96
Andover 91
Grafing 84
Council Bluffs 83
Nanjing 82
Seoul 81
Ho Chi Minh City 80
Toronto 79
Hanoi 69
Houston 66
New York 58
Des Moines 55
Palermo 53
Wilmington 52
Dong Ket 47
Abuja 44
Civitanova Marche 43
São Paulo 38
Dakar 37
Buffalo 33
Rome 33
Columbus 30
San Mateo 30
The Dalles 28
Hebei 27
Lagos 27
Helsinki 26
Hong Kong 25
Nanchang 25
Orem 25
Saint Petersburg 22
Warsaw 21
Messina 20
Shenyang 19
Frankfurt am Main 17
Da Nang 16
Jiaxing 16
Lappeenranta 16
Milan 16
Tokyo 16
Acireale 15
Guangzhou 15
Johannesburg 15
Naples 15
Amsterdam 14
Belo Horizonte 14
Bremen 14
Falls Church 14
Mexico City 14
Montreal 13
Rio de Janeiro 13
Dearborn 12
Padova 12
Baghdad 11
Brooklyn 11
Curitiba 11
Nuremberg 11
Ottawa 11
Phoenix 11
Denver 10
Haiphong 10
London 10
Munich 10
Tianjin 10
Augusta 9
Chennai 9
Mumbai 9
Port Harcourt 9
Redwood City 9
Aci Catena 8
Ankara 8
Boston 8
Florence 8
Jinan 8
Kochi 8
Mascalucia 8
Nairobi 8
Norwalk 8
Poplar 8
Stockholm 8
Turin 8
Changsha 7
Totale 8.339
Nome #
Gut Microbiota and Cancer: From Pathogenesis to Therapy 259
Advances in targeting signal transduction pathways. 246
Benefits and concerns of probiotics: an overview of the potential genotoxicity of the colibactin-producing Escherichia coli Nissle 1917 strain 221
Diagnostic and Prognostic Significance of a Four-miRNA Signature in Colorectal Cancer 200
Glioblastoma mesenchymal subtype enhances antioxidant defence to reduce susceptibility to ferroptosis 187
Co-Occurrence of Interleukin-6 Receptor Asp358Ala Variant and High Plasma Levels of IL-6: An Evidence of IL-6 Trans-Signaling Activation in Deep Vein Thrombosis (DVT) Patients 184
Computational modelling in melanoma for novel drug discovery 178
Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells 173
Computational identification of microRNAs associated to both epithelial to mesenchymal transition and NGAL/MMP-9 pathways in bladder cancer 170
Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy 167
Analysis of the RAC1 mutations in cutaneous melanoma patients with occupational sun exposure 167
Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells 165
Methylation‑sensitive restriction enzyme‑droplet digital PCR assay for the one‑step highly sensitive analysis of DNA methylation hotspots 164
Droplet digital pcr analysis of liquid biopsy samples unveils the diagnostic role of hsa-mir-133a-3p and hsa-mir-375-3p in oral cancer 161
Bioinformatic analysis of the LCN2–SLC22A17–MMP9 network in cancer: The role of DNA methylation in the modulation of tumor microenvironment 159
Computational modeling of PI3K/AKT and MAPK signaling pathways in melanoma cancer 158
A Tailored Health Surveillance Program Unveils a Case of MALT Lymphoma in a HCV-positive Health-Care Worker 156
MMP-9 overexpression is associated with intragenic hypermethylation of MMP9 gene in melanoma 154
Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells 153
Dysregulation of IL-6 cis- and trans-signaling and high frequency of IL6R rs2228145(C>A) in the management of Deep Vein Thrombosis 145
Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine 145
Analysis of the B-RafV600E mutation in cutaneous melanoma patients with occupational sun exposure 144
Prognostic significance of deregulated microRNAs in uveal melanomas 141
EpiMethEx: a tool for large-scale integrated analysis in methylation hotspots linked to genetic regulation 138
Identification of the most common BRCA alterations through analysis of germline mutation databases: Is droplet digital PCR an additional strategy for the assessment of such alterations in breast and ovarian cancer families? 138
Identification of SLC22A17 DNA methylation hotspot as a potential biomarker in cutaneous melanoma 136
The analysis of miRNA expression profiling datasets reveals inverse microRNA patterns in glioblastoma and Alzheimer's disease 136
Identification of novel microRNAs and their diagnostic and prognostic significance in oral cancer 136
Cutaneous melanoma: From pathogenesis to therapy 135
MMP-9 as a marker-of response to treatment with B-Raf inhibitors in cutaneous melanoma 134
BRAF mutations in papillary thyroid carcinoma and emerging targeted therapies (review) 130
DNA methylation and gene expression in melanoma: A large-scale integrated analysis 130
Analisi delle mutazioni Rac1 nei lavoratori con melanoma cutaneo esposti al sole per motivi professionali 129
Pericytes in microvessels: From “mural” function to brain and retina regeneration 129
Pomegranate: A promising avenue against the most common chronic diseases and their associated risk factors (Review) 127
Analysis of PIK3CA mutations in cutaneous melanoma patients with occupational sun exposure 126
Nitric Oxide in Hematological Cancers: Partner or Rival? 126
Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response 122
Emerging targeted therapies for melanoma treatment (review) 122
Role of microRNAs as novel diagnostic biomarkers and potential therapeutic targets for hearing disorders (Review) 121
Prediction of PD‐l1 expression in neuroblastoma via computational modeling 121
Overactivation of IL6 cis‑signaling in leukocytes is an inflammatory hallmark of deep vein thrombosis 118
microRNAs and thyroid cancer: Biological and clinical significance (Review). 113
Role of Oral Microbiota Dysbiosis in the Development and Progression of Oral Lichen Planus 113
MMP-9 as a candidate marker of response to BRAF inhibitors in melanoma patients with BRAFV600Emutation detected in circulating-free DNA 112
Correlation between the overexpression of Yin Yang 1 and the expression levels of miRNAs in Burkitt's lymphoma: A computational study 111
Environment and bladder cancer: Molecular analysis by interaction networks 108
Functional Roles of Matrix Metalloproteinases and Their Inhibitors in Melanoma 108
Clinical Relevance of Targeted Therapy and Immune-Checkpoint Inhibition in Lung Cancer 108
Integrated analysis of colorectal cancer microRNA datasets: Identification of microRNAs associated with tumor development 106
Role of the transcription factor Yin Yang 1 and its selectively identified target survivin in high-grade b-cells non-Hodgkin lymphomas: Potential diagnostic and therapeutic targets 103
In silico analysis of the solute carrier (SLC) family in cancer indicates a link among DNA methylation, metabolic adaptation, drug response, and immune reactivity 100
Gene alterations in the PI3K/PTEN/AKT pathway as a mechanism of drug-resistance 100
Cancer therapy and treatments during COVID-19 era 100
Patient-derived tumor organoids for drug repositioning in cancer care: A promising approach in the era of tailored treatment 98
Osteopontin/Matrix metalloproteinases pathway is not activated in cervical carcinoma 97
Cutaneous melanoma and the immunotherapy revolution (Review) 94
Functions of NGAL and GSK-3beta in sensitivity to targeted, chemo- and hormonal-based therapies 93
Regulation of GSK-3 activity by curcumin, berberine and resveratrol: Potential effects on multiple diseases. 93
Fluoro-edenite induces fibulin-3 overexpression in non-malignant human mesothelial cells 92
Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cells 92
Novel insights into epigenetic regulation of il6 pathway: In silico perspective on inflammation and cancer relationship 92
Low levels of inflammation and the absence of subclinical atherosclerosis in rheumatoid arthritis 90
Direct oral anticoagulant treatment of deep vein thrombosis reduces IL‑6 expression in peripheral mono‑nuclear blood cells 88
Roles of EGFR and KRAS and their downstream signaling pathways in pancreatic cancer and pancreatic cancer stem cells 88
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance. 88
MMP-9 is a candidate marker of response to treatment with dabrafenib in melanoma cells 88
Roles of signaling pathways in drug resistance, cancer initiating cells and cancer progression and metastasis 87
Low Glycemic Index Diet, Exercise and Vitamin D to Reduce Breast Cancer Recurrence: Rationale for the Design of a Clinical Trial 85
Effects of berberine, curcumin, resveratrol alone and in combination with chemotherapeutic drugs and signal transduction inhibitors on cancer cells-Power of nutraceuticals. 85
Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinases (MMPs) as biomarkers of bladder cancer development and progression 84
Prevalence of hepatitis C virus infection among health-care workers: A 10-year survey 83
Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals 82
Osteopontin/Matrix metalloproteinases pathway is not activated in cervical carcinoma 81
Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinases (MMPs) as biomarkers of bladder cancer development and progression 80
Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals 80
Overexpression of Sthamin-1 in lung cancer from patients exposed to asbestos: an "in silico" evaluation 78
Targeting signaling pathways involved in metastasis in cancer stem cells 77
Suppressing prostate cancer by targeting NGAL 76
Metformin influences drug sensitivity in pancreatic cancer cells 75
Roles of p53, NF-κB and the androgen receptor in controlling NGAL expression in prostate cancer cell lines 75
Overexpression of Sthamin-1 is associated with the development of lung cancer developed in patients exposed to asbestos 75
Overexpression of nectin like-5 is associated with a malignant phenotype in cutaneous melanoma 74
Interaction between matrix metalloproteinase-9 (MMP-9) and neutrophil gelatinase-associated lipocalin (NGAL): A recent evolutionary event in primates 74
Implication of IL-6 in the development of HCV-associated non-Hodgkin lymphoma 73
The tumor microenvironment in hepatocellular carcinoma 72
Detection of B-Rat mutations in ovarian cancer is associated with chemoresistance 71
Neopterin: a potential marker in chronic peripheral arterial disease 71
Effects of Ectopic Expression of NGAL on Doxorubicin Sensitivity. 71
Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs 71
Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells 70
Diagnostic value of neutrophil gelatinase-associated lipocalin/matrix metalloproteinase-9 pathway in transitional cell carcinoma of the bladder 70
Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-family member expression 70
Interactions between immune and environmental stimuli in non-Hodgkin Lymphoma 70
Osteopontin/matrixmetalloproteinasis pathway activation in head and neck cancer 70
Vitamin D and microRNAs: Role in the pathogenesis and prognosis of breast cancer (Review) 69
Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer 69
NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance 69
V600E B-Raf mutation is associated with chemoresistance in ovarian cancer 69
Transcription analysis of Neutral Associated Lipocalin (NGAL) in Hepatocellular Carcinoma 69
Totale 11.401
Categoria #
all - tutte 41.332
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.332


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202158 0 0 0 0 0 0 0 0 0 0 0 58
2021/2022727 62 107 5 33 102 15 100 25 52 23 21 182
2022/20231.326 114 69 30 144 118 201 11 208 321 25 56 29
2023/2024540 20 80 32 27 24 100 25 34 11 20 93 74
2024/20252.652 24 390 143 142 589 286 131 103 210 266 176 192
2025/20265.920 328 511 1.073 394 786 1.063 666 146 302 365 190 96
Totale 12.536